ETISEQ – an algorithm for automated elution time ion sequencing of concurrently fragmented peptides for mass spectrometry-based proteomics by Wong, Jason WH et al.
BioMed  Central
Page 1 of 10
(page number not for citation purposes)
BMC Bioinformatics
Open Access Methodology article
ETISEQ – an algorithm for automated elution time ion sequencing 
of concurrently fragmented peptides for mass spectrometry-based 
proteomics
Jason WH Wong*1, Alexander B Schwahn2 and Kevin M Downard2
Address: 1UNSW Cancer Research Centre, University of New South Wales, Sydney, NSW 2052, Australia and 2School of Molecular and Microbial 
Biosciences, University of Sydney, Sydney, NSW, 2006, Australia
Email: Jason WH Wong* - jason.wong@unsw.edu.au; Alexander B Schwahn - aschwahn@usyd.edu.au; 
Kevin M Downard - kdownard@usyd.edu.au
* Corresponding author    
Abstract
Background: Concurrent peptide fragmentation (i.e. shotgun CID, parallel CID or MSE) has
emerged as an alternative to data-dependent acquisition in generating peptide fragmentation data
in LC-MS/MS proteomics experiments. Concurrent peptide fragmentation data acquisition has
been shown to be advantageous over data-dependent acquisition by providing greater detection
dynamic range and providing more accurate quantitative information. Nevertheless, concurrent
peptide fragmentation data acquisition remains to be widely adopted due to the lack of published
algorithms designed specifically to process or interpret such data acquired on any mass
spectrometer.
Results: An algorithm called Elution Time Ion Sequencing (ETISEQ), has been developed to enable
automated conversion of concurrent peptide fragmentation data acquisition data to LC-MS/MS
data. ETISEQ generates MS/MS-like spectra based on the correlation of precursor and product ion
elution profiles. The performance of ETISEQ is demonstrated using concurrent peptide
fragmentation data from tryptic digests of standard proteins and whole influenza virus. It is shown
that the number of unique peptides identified from the digests is broadly comparable between
ETISEQ processed concurrent peptide fragmentation data and the data-dependent acquired LC-
MS/MS data.
Conclusion: The ETISEQ algorithm has been designed for easy integration with existing MS/MS
analysis platforms. It is anticipated that it will popularize concurrent peptide fragmentation data
acquisition in proteomics laboratories.
Background
Liquid chromatography (LC) coupled electrospray ioniza-
tion (ESI)-tandem mass spectrometry (MS/MS) [1] has
been one of the essential proteomics enabling technolo-
gies [2,3]. While technological improvements are contin-
ually being made in chromatography [4], mass
spectrometry [5,6] and mass spectra interpretation algo-
rithms [7], the detection of lower abundance proteins or
proteolytic peptides in complex mixtures remains an
obstacle in most proteomics experiments [8,9]. These
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dynamic range limitations arise in LC-MS/MS experi-
ments, in part, as a result of the inability to completely
resolve all peptide ions by liquid chromatography. The
use of multidimensional liquid chromatography, where
peptides are resolved using two or more separation prin-
ciples, can improve the dynamic range of detection [10].
Nevertheless, in complex proteomic samples, multiple
peptides are still likely to co-elute.
In order to acquire tandem mass spectra for as many pep-
tide ions as possible, the vast majority of tandem mass
spectrometers are able to perform data-dependent acqui-
sition (DDA). Data-dependent acquisition of LC-MS/MS
data has been the principal method for collecting peptide
fragmentation data for both protein identification and
quantification. During this process, a preliminary survey
MS scan is acquired to identify the peptide ions that elute
into the ion source at any point in time. This is followed
by one or a series of MS/MS scans to isolate and dissociate
each peptide ion in turn, typically in decreasing order of
their ion signal abundance. Exclusion lists can be used to
prevent repeated sequencing of highly abundant ions that
may limit the chance of sample peptide ions from being
sequenced. Lists containing m/z values of solvent cluster
ions, buffer or other known protein contaminants such as
keratin may be also used. Nevertheless, DDA may still
overlook low abundance ions.
A second disadvantage of DDA is its inability to accurately
quantitate peptides in proteomics mixtures. Quantitative
information is derived from the selected ion chromato-
grams (SICs) generated for each of the peptides from the
survey MS scans. As the number of peptides ions subjected
to tandem mass spectrometry increases per survey MS
scan, there will be fewer MS scans from which to quanti-
tate ions during the course of an LC-MS/MS experiment.
Ultimately, this will affect the reliability of comparative
protein quantification using isotopic labelling [11] or
label-free methods [12].
To overcome limitations of DDA-based experiments, the
concept of concurrent peptide fragmentation data acquisi-
tion (CDA) has been shown to be both feasible [13-15]
and provides excellent reproducibility and peptide cover-
age [16]. During CDA, each survey MS scan is followed by
a MS/MS-like scan in which all peptide ions are concur-
rently dissociated either within the ion source [17] or the
dissociation cell [18]. CDA has been variably termed shot-
gun CID [13], parallel CID [15] and MSE [16]. The advan-
tage of CDA is that in theory all peptide ions will be
fragmented regardless of their signal intensity. Further-
more, since CDA acquires survey MS data every alternate
scan, quantitative information can be obtained more reli-
ably in comparison to DDA data.
Despite the advantages of CDA over DDA, the method has
not been widely adopted. The major reason for this is that,
with the exception of a platform specific software package
[16], there are no publicly available algorithms designed
specifically to process or interpret CDA data acquired on
any mass spectrometer. To enable automated analysis, an
algorithm termed elution time ion sequencing (ETISEQ)
has been designed for processing any CDA data. Using LC
elution profiles of precursor and product ions, ETISEQ
automatically reconstructs MS/MS-like spectra for pep-
tides which have been concurrently fragmented. In doing
so it converts the CDA data into a DDA-like LC-MS/MS
dataset (Figure 1). This manuscript describes the design
and development of the algorithm. The performance of
the algorithm is demonstrated using real CDA data from
protein samples with increasing numbers of proteolytic
peptides. The output results are compared with DDA data
recorded for the same samples.
Results
Description and basis of the ETISEQ algorithm
The ETISEQ algorithm will be described stepwise as out-
lined in Figure 1 from steps A to G.
Input file format (A)
ETISEQ has been designed to process CDA data. For the
purpose for this algorithm, CDA data is defined as an LC-
MS experiment where, throughout the duration of the
experiment, survey MS scans are alternated with MS/MS-
like scans. These scans will be typically odd and even
numbered respectively. To maximize the compatibility of
the algorithm with mass spectrometers, ETISEQ accepts
CDA data in mzXML format.
Generation of an ion exclusion list (B)
Since all ions are fragmented during CDA, it is useful to
exclude precursor and product ions that are known to be
contaminants [19]. ETISEQ has been designed to be able
to search for ions that are present in more than 25% of
scans. Ions which appear in more than 25% of scans are
considered unlikely to be of peptide ions since their detec-
tion would be independent of chromatographic separa-
tion. Known common LC-MS/MS contaminants [19] can
also be manually added to an exclusion list. Ions on the
exclusion list will not be considered for all subsequent
steps in the algorithm.
Ion selection from survey and MS/MS-like scans (C)
Ion selection from survey and MS/MS-like scans is an
important component of the ETISEQ algorithm since it
predetermines the number and quality of reconstructed
MS/MS-like spectra. A selected number (n) of ions for
which a MS/MS spectrum is reconstructed can be defined
for each scan. Selected precursor ions can then beBMC Bioinformatics 2009, 10:244 http://www.biomedcentral.com/1471-2105/10/244
Page 3 of 10
(page number not for citation purposes)
Schematic diagram of the ETISEQ algorithm Figure 1
Schematic diagram of the ETISEQ algorithm. The major steps of the algorithm are labelled from A to G and explained 
in the text.BMC Bioinformatics 2009, 10:244 http://www.biomedcentral.com/1471-2105/10/244
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excluded from further selection of a given number (x) of
subsequent scans. The advantage of excluding previously
sampled peptide ions is that it allows the reconstruction
of MS/MS-like spectra for lower abundance ions while
avoiding the generation of redundant MS/MS-like spectra.
Selection of ions from MS/MS-like scans is based on a
noise threshold (typically > 0.01 of base peak intensity).
For both survey and MS/MS-like scans, the ETISEQ algo-
rithm automatically excludes all but the most abundant
ion of an isotopic cluster of peaks.
Computation of SIC for selected peaks (D)
SICs enable the elution time and profiles of precursor and
product ions to be correlated. These are computed for all
selected peaks from the survey and MS/MS-like scans. SICs
are computed over a selected time range (30s either side
of the time of detection of a given ion was found to be
adequate). Time defined SIC will ensure that related pre-
cursor and product ions are correlated accurately since a
precursor ion and its product ion will have identical elu-
tion times and profiles while other ions of similar or iden-
tical m/z may exist but will elute at different points in
time. Generating time defined SIC also improves the
speed of the algorithm as it limits the number of data
points that need to be compared.
Correlation of SICs of ions from survey and MS/MS-like 
scans (E)
The lineage of product ions to the precursor ions are pre-
dicted based on the correlation of their SICs. This is
referred to as precursor-product ion association. There are
two components which determine whether two SICs are
significantly correlated. First, each peptide is expected to
have a distinct elution time. The elution profile (i.e. the
peak shape in a SIC) is also expected to be unique to each
peptide. Figure 2 shows a number of SICs for different
ions in the MS/MS-like spectrum.
To compare the elution time of ions, fast Fourier trans-
form (FFT) cross-correlation is used to rapidly determine
whether two ions eluted at the same time based on their
SICs. The calculation of the cross-correlation function
using FFT is a well-known method for measuring correla-
tion and time delay/lag between 1D and 2D signals in sig-
nal processing [20]. In proteomics, FFT cross-correlation
has been used in a variety of applications, including tan-
dem mass spectra database searching, as in the SEQUEST
algorithm [21], and for the alignment of chromatograms
and mass spectra [22]. FFT cross-correlation has the attrac-
tive property of being computationally efficient for find-
ing the maximal correlation between two data sets where
one signal may be shifted relative to another. FFT cross-
correlation is superior to comparing peak maxima since
the elution profile is taken into consideration and there-
fore the comparison is more resilient to noise.
For the comparison of the actual shape of the elution pro-
file, the Pearson's correlation coefficient [23] is used to
indicate the strength of a linear relationship between two
SICs. Pearson's correlation coefficient ranges from +1 to -
An example of a reconstructed MS/MS-like spectrum Figure 2
An example of a reconstructed MS/MS-like spectrum. The MS/MS-like spectra is reconstructed from an in-source CID 
MS/MS-like spectrum with two selected peptide ions from the survey scan. The dotted arrows show some of the product ions 
unique to each reconstructed MS/MS spectrum.BMC Bioinformatics 2009, 10:244 http://www.biomedcentral.com/1471-2105/10/244
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1. A correlation value of +1 indicates identical positive
relationship between two SICs, 0 indicates that two SICs
are unrelated and -1 indicates a negative relationship
between two SICs. Based on the tested datasets, it was
found that an absolute lag of 1 scan and a correlation coef-
ficient of greater than 0.7 was most effective for the corre-
lation of precursor and product ions (data not shown).
Where multiple product ions are correlated to more than
one precursor ions, the product ions are assigned to all
correlating precursor ions. When a product ion does not
match any precursor ion, it is assigned to all precursor
ions. For the datasets used for testing ETISEQ, such prod-
uct ions are typically of low abundance and therefore
results in the generation of SICs that contain significant
machine noise (data not shown).
Reconstruction of MS and MS/MS-like spectra (F)
Survey MS scans from CDA data are identical to survey MS
scans from DDA data. For each selected precursor ion evi-
dent in a survey MS scan, a MS/MS spectrum is recon-
structed by elution time correlation of precursor and
product ions. Product ions that do not significantly corre-
late with any precursor ion are included in all correspond-
ing reconstructed MS/MS-like spectra. An example of a
reconstructed MS/MS-like spectra generated from an in-
source CID spectrum of two peptides is shown in Figure 2.
Generation of output DDA-like LC-MS/MS data (G)
Steps C to F, described above, are repeated for each pair of
survey MS and MS/MS-like scans. Once all scans have
been processed, ETISEQ uses all reconstructed spectra to
generate DDA-like LC-MS/MS data in mzXML file format.
Implementation of the ETISEQ algorithm
The ETISEQ algorithm was implemented using C++ and is
compatible with Windows XP/Vista, Linux and Mac OS ×
operating systems. The standalone executable and a web
interface for ETISEQ can be accessed at the following URL
address: http://www.cancerresearch.unsw.edu.au/
CRCWeb.nsf/page/Elution+time+ion+sequencing. The
time taken for ETISEQ to run will depend on the parame-
ters, but in general the time required does not exceed 10
minutes. mzXML viewers and inter-conversion tools can
be found at the NHLBI Proteomics Center at the Institute
for Systems Biology [24].
Testing
Optimization of ETISEQ parameters
The key parameters which determine the reconstruction of
MS/MS-like spectra are the maximum number of selected
precursor ions from the survey MS scans (n) and the
number of scans (x) in which the selected ions are
excluded. To optimise the parameters, a range of values
were used in combination, and the optimal values were
determined based on the number of identified unique
peptides for the BSA proteolytic sample. From Figure 3, it
can be seen that between 15 and 24 unique peptides could
be identified from the reconstructed MS/MS-like spectra.
As n increases, the number of identified unique peptides
generally plateaus above a maximum of 5 ions per
selected scan. Increasing x  from 0 to 5 was found to
increase the number of identified unique peptides. The
optimal value in this case was to select a maximum of 5
ions per scan and exclude the selected ions for the next 4
scans (i.e. n = 5 and x = 4). The choice of parameters is
likely to vary depending on the chromatography condi-
tions and the complexity of the sample analysed and can
be easily adjusted by the user through the ETISEQ web-
interface.
Other parameters that that can be adjusted by the user
include the addition of the option to exclude contami-
nants. Furthermore, to increase the speed of the ETISEQ
algorithm and to reduce the number of reconstructed MS/
MS-like spectra of non-peptide origin, it was found that it
is beneficial to predefine the range of scans over which
MS/MS reconstruction is performed. This range can usu-
ally be estimated by visualization of the CDA data to
determine the elution times where the peptide ions are
first and last detected.
All remaining parameters described in the previous sec-
tion such as the SIC time range and correlation coefficient
cut-off were found to require less optimisation and are
therefore not direct user adjustable through the web-inter-
face. Nevertheless, these can be adjusted in the standalone
version of ETISEQ which can be requested from the
authors.
Parameter optimization Figure 3
Parameter optimization. Relationship between the maxi-
mum number of peptide ions selected for each scan, n (x-
axis), number of subsequent scans to exclude selected ions, 
x, (depicted by different lines and dots) and the number of 
unique peptides identified for the BSA digest (y-axis).BMC Bioinformatics 2009, 10:244 http://www.biomedcentral.com/1471-2105/10/244
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ETISEQ performance validation
In order to demonstrate the utility of the described algo-
rithm, the numbers of peptides identified for tryptic pro-
tein digests of hen egg lysozyme and BSA, as well as a
tryptic digest of whole influenza virus were compared
using DDA data and CDA data with ETISEQ processing.
The parameters used for ETISEQ were 5 selected precursor
ions per spectra (n = 5) and these were excluded for 4 sub-
sequent scans (x = 4) as previously determined to be opti-
mal. DDA-like LC-MS/MS data were also generated from
CDA data without precursor-product ion correlation
processing. This was necessary to demonstrate the benefit
of ion correlation on automated MS/MS spectra interpre-
tation.
Table 1 shows that the DDA data resulted in the highest
number of unique peptides for identified lysozyme and
the virus digest (8 and 20 unique peptides respectively),
while CDA data processed with ETISEQ identified most
for BSA (24 unique peptides – for full list of peptides [see
Additional file 1]). In all cases, CDA without correlation
processing resulted in the least number of identified
unique peptides. Based on the overall peptide coverage of
the virus digest (Table 2), it can be seen that the some of
the identified peptides are different between DDA and
CDA acquired data.
The distribution of the relative abundance of precursor
ions that were correctly identified was also examined. For
all three samples analysed it was found that, in compari-
son to DDA, CDA resulted in the identification of precur-
sor ions with a broader range of relative intensities as well
as lower median and minimum relative intensities (Figure
4).
Discussion
The results demonstrate that CDA generated data can be
readily used for protein identification when processed
using the described algorithm. While proteins can still be
identified from CDA data without correlation processing
of precursor and product ion lineage, the results show that
it is advantageous to do so (Table 1). This is expected as
the presence of unrelated product ions in MS/MS spectra
will lead to erroneous identifications by MS/MS spectra
interpretation algorithms [25]. The peptide identification
results for ETISEQ generated DDA-like LC-MS/MS data are
broadly comparable to DDA data (Table 1). For the whole
influenza virus digest, there were a number of identified
peptides that were unique to CDA data despite the fact
that less unique peptides were identified for the recon-
structed LC-MS/MS data in comparison to DDA data
(Table 2). This is expected as, unlike DDA, CDA experi-
ments will sample peptides independent of its abundance
and generate peptide fragment data of all peptides.
Indeed, Figure 4 shows that the distribution of CDA data
sampled was more tailed with a lower median compared
to DDA data, indicating that more low abundance ions
were sequenced in CDA experiments.
For the virus digest (Table 2). It should be noted that pep-
tides unique to CDA were in all cases a subsequence of the
tryptic peptides detected in DDA. This may be due to the
generation of in-source fragments during precursor ions
scans resulting from incomplete evacuation of the cooling
gas following a product ion scan. The acquisition of CDA
data by true MS/MS should alleviate this problem. Never-
theless, the ability of ETISEQ to generate MS/MS spectra
for such ions demonstrates the utility of the software.
In part, the difference in the identified peptides may be
explained by the differing product ions that are generated
during CDA and single peptide MS/MS data. In the exper-
iments described, concurrent peptide fragmentation was
achieved in the ion source where ions are accelerated
across the source under atmospheric pressure. For DDA
data, the dissociation of peptide ions occurs within a col-
lision cell or chamber. While both methods generally
yield b- and y- type product ions [26], in-source CID pro-
duces product ions under a different environment in the
presence of residual solvent and other atmospheric gases.
CDA can be performed on single mass analyser instru-
ments (without tandem MS capabilities). Furthermore,
the detection efficiency for fragment and precursor ions
can be enhanced since both have shorter paths to the
detector. It is important to realise that in the case of CDA
experiments, the possibility of performing true tandem
Table 1: Total number of unique peptides identified using MS/MS spectra interpretation algorithms for lysozyme, BSA and virus 
digests.
Unique peptides^
Lysozyme BSA Virus
DDA 8 (60.5%) 21 (36.2%) 20
CDA – ETISEQ processed 7 (52.4%) 24 (32.3%) 15
CDA – no correlation processing 6 (52.4%) 19 (27.0%) 10
^ For lysozyme and BSA, the respective sequence coverage is shown in brackets. The data are generated by data dependent LC-MS/MS and CDA 
with and without ETISEQ processing. [See Additional file 1] for protein/peptide list.BMC Bioinformatics 2009, 10:244 http://www.biomedcentral.com/1471-2105/10/244
Page 7 of 10
(page number not for citation purposes)
experiment is not excluded. This may be achieved by
adjustment of ion focusing to allow for the transmission
of all precursor ions (at once) into a collision cell [15]. In
this instance, and in in-source CID experiments, different
multiply charged ions of a common peptide are collec-
tively fragmented thereby increasing the overall product
ion intensities and improving the signal-to-noise ratio.
It is anticipated that CDA along with ETISEQ processing,
will be most advantageous for quantitative experiments
that make use of affinity enrichment and isotope labelling
such as isotope-coded affinity tags [11]. In comparison to
DDA it can be expected that CDA will produce more SIC
data points for peptide ions since survey MS scans are
always performed every alternate scan. In contrast to CDA,
it is common in DDA that survey MS scans are only
acquired every 3–4 scans. The same quantitative advan-
tage can be expected for label-free MS-based experiments
that make use of SICs [27].
Conclusion
The ETISEQ algorithm enables automated processing of
CDA data for protein identification. The algorithm has the
ability to discover precursor-product ion lineages in order
to reconstruct MS/MS-like spectra. It enables the conver-
sion of CDA data to DDA-like LC-MS/MS data. The
ETISEQ algorithm has been designed to input and output
the data in mzXML file format to ensure maximum com-
patibility with data from different MS instruments and
downstream MS/MS analysis platforms.
A comparison of database search results from DDA and
ETISEQ processed CDA data for tryptic digest of two
standard proteins and whole virus demonstrate that
results from both strategies are comparable in their per-
formance. Importantly, the use of the ETISEQ algorithm
on CDA data significantly increased the number of unique
peptides identified. It was also found that CDA samples a
wide abundance of peptide ions in comparison to DDA.
Table 2: Summary of proteins and identified unique peptides for the tryptic digest of the influenza virus preparation.
Peptides^
Accession Description DDA CDA – ETISEQ
P03466 Nucleoprotein – Influenza A MVLSAFDER (2+) -
(Puerto Rico/8/1934 H1N1) ASAGQISIQPTFSVQR (2+) ASAGQISIQPTFSVQR (2/3+)
TTIMAAFNGNTEGR (2+) -
MMESARPEDVSFQGR (3+) MMESARPEDVSFQGR (2/3+)
ESARPEDVSFQGR (2+) ESARPEDVSFQGR (2+)
- SARPEDVSFQGR (2+)
[10.8%] [6.2%]
gi|33622382 Hemagglutinin – Influenza A EVLVLWGVHHPPNIGNQR (3+) EVLVLWGVHHPPNIGNQR (3+)
(New Caledonia/20/1999 H1N1) ALYHTENAYVSVVSSHYSR (3+) ALYHTENAYVSVVSSHYSR (3+)
- HPPNIGNQR (2+)
[6.6%] [6.6%]
gi|22859465 Matrix protein 1 – Influenza A QMVTTTNPLIR (2+) QMVTTTNPLIR (2+)
(New Caledonia/20/1999 H1N1)
[5.2%] [5.2%]
P01012 Ovalbumin – Gallus gallus GGLEPINFQTAADQAR (2+) GGLEPINFQTAADQAR (2+)
NVLQPSSVDSQTAMVLVNAIVFK (3+) -
AFKDEDTQAMPFR (3+) -
LTEWTSSNVMEER (2+) LTEWTSSNVMEER (2+)
ISQAVHAAHAEINEAGR (3+) ISQAVHAAHAEINEAGR (3+)
[21.2%] [11.9%]
P02789 Ovotransferrin precursor – Gallus gallus VEDIWSFLSK (2+) -
YFGYTGALR (2+) YFGYTGALR (2+)
GDVAFIQHSTVEENTGGK (3+) -
ECNLAEVPTHAVVVRPEK (3+) -
FMMFESQNK (2+) -
[9.1%] [1.3%]
P01014 Ovalbumin-related protein Y – Gallus gallus YNPTNAILFFGR (2+) YNPTNAILFFGR (2+)
- PTNAILFFGR (2+)
HSLELEEFR (2+) HSLELEEFR (2+)
[5.4%] [5,4%]
^The sequence coverage of each protein is shown in square brackets. The data are acquired by DDA and CDA with ETISEQ processing. Note that 
the virus was cultured in 10–14 day old embryonic hen eggs (Gallus gallus) and therefore chicken proteins are expected.BMC Bioinformatics 2009, 10:244 http://www.biomedcentral.com/1471-2105/10/244
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With further optimization of the CDA peptide fragmenta-
tion process, it can be anticipated that ETISEQ will be of
great value to enable CDA where quantification is
required.
Methods
Materials
All standard chemicals were purchased from commercial
sources and were all of analytical grade, unless stated oth-
erwise. Protease inhibitor cocktail and modified trypsin
(sequence grade) were obtained from Promega (Madison,
WI, USA). Influenza strain A/New Caledonia/20/99
IVR116 (H1N1) was obtained from Advanced Immuno-
Chemicals Inc. (Long Beach, California USA) as an inacti-
vated virus preparation from the allantoic fluid of 10–11
day old embryonated eggs. All other chemicals and rea-
gents were obtained from Sigma-Aldrich (Sydney, Aus-
tralia).
Proteolytic sample preparation
In-solution tryptic digestion of the proteins and virus was
performed. Briefly, standard proteins lysozyme and
bovine serum albumin (BSA) were adjusted to a concen-
tration of 1 mg/mL in 50 mM NH4HCO3, pH 7. Samples
were reduced with DTT, and treated with iodoacetamide
to alkylate cysteines and then incubated with trypsin at
37°C overnight. For the influenza virus, 50 μg of the virus
(corresponding to 38.5 μL of the virus suspension) were
concentrated to near dryness in a vacuum concentrator,
resuspended in 50 μL digestion buffer (50 mM
NH4HCO3, 10% Acetonitrile, 2 mM DTT) and incubated
at 37°C for 4 h prior to the addition of trypsin and over-
night digestion. All digestions were performed at a 1:100
trypsin to protein ratio.
Liquid chromatography – Mass spectrometry
Proteolytic samples were analysed by LC-MS, using a
nanoflow HPLC system (Agilent 1100, Agilent Technolo-
gies) coupled with a quadrapole time-of-flight mass spec-
trometer (QStar XL Hybrid, Applied Biosystems)
equipped with a nanospray source. Samples were loaded
onto a reverse phase C18 column (Zorbax Eclipse XDB, 5
μm, 0.3 × 150 mm) and eluted into the ion source at a
flow rate of 0.8 μL/min using a mobile phase of H2O
(Buffer A)/acetonitrile (Buffer B). Specifically, the gradi-
ent conditions were as follows: 95:5 (A:B) at 0 min,
changing linearly to 90:10 (A:B) at 5 min, changing line-
arly to 50:50 (A:B) at 40 min, changing linearly to 30:70
(A:B) at 45 min, changing linearly to 95:5 (A:B) at 50 min
and then unchanged until the completion of the run at 60
min.
To acquire CDA data, an instrument method was created
to acquire alternate survey MS scans followed by in-source
induced fragmentation to create MS/MS-like spectra. The
alternation was set for the entire duration of the LC-MS
experiment. To induce in-source fragmentation of pep-
tides, the declustering potential (potential between the
orifice plate and the skimmer) was increased from a typi-
cal value of 50 V to 155 V, while the collision cooling gas
pressure was also increased from the typical value of 3 to
8 (arbitrary units). For DDA, the two most abundant ions
for each survey MS scan were selected for subsequent MS/
MS analysis. Once a MS/MS spectrum was acquired for a
given ion, it is excluded from a further MS/MS experiment
for the next 30 seconds. For all downstream data analysis,
data files in .wiff format were centroided and converted to
mzXML format using the MzWiff software [28].
It should be noted that the acquisition of CDA data by
passing all peptides into a collision cell was attempted.
However, it was found that this could not be achieved effi-
ciently on the QStar XL Hybrid used in this experiment. As
a result, in-source induced dissociation was performed as
an alternative.
Data analysis
All CDA and DDA LC-MS/MS data in mzXML file format
were analysed using the InsPecT (version 20080404) [29],
X!Tandem (version 2008.02.01) [30] and OMSSA (ver-
sion 2.1.1) [31] algorithms with a custom database which
includes all Gallus gallus and influenza virus proteins, BSA,
trypsin and human keratin proteins within the Uni-
protKB/Swiss-Prot database (Release 56.0, 22-Jul-2008).
Distribution of relative abundances of peptides sampled Figure 4
Distribution of relative abundances of peptides sam-
pled. The box-plot shows the distribution of the relative 
intensity of precursor ions of MS/MS (DDA) and recon-
structed MS/MS-like (CDA) spectra for the lysozyme, BSA 
and whole virus preparation tryptic digest. The lines indi-
cated the maximum and minimum relative abundances, the 
box edges indicate the first and third quartile of relative 
abundances and the cross (+) indicates the median relative 
abundance.BMC Bioinformatics 2009, 10:244 http://www.biomedcentral.com/1471-2105/10/244
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Influenza strain A/New Caledonia/20/99 (H1N1) pro-
teins retrieved from the Influenza Virus Resource provided
by the National Center for Biotechnology Information
were also included. Multiple search algorithms were used
to reduce the likelihood of false positive identifications as
well as to maximise the number of peptides identified.
Database search parameters were set at 2.5 Da and 0.5 Da
for precursor and product ion error tolerance respectively.
Semi-tryptic digestion allowing for 2 missed cleavages was
used. Carbamidomethyl cysteine, and the possibility of
methionine oxidation and pyroglutamate formation,
were specified. Peptide identification acceptance cut-offs
values of p-value < 0.025 for InsPect, e-value < 0.01 for
X!Tandem and e-value < 0.025 for OMSSA were used. The
cut-offs are determined from an observed 1% false posi-
tive rate (FDR) using a random decoy database [32]. FDR
is defined as, False Positives/(True Positives+False Posi-
tives). Specifically, cut-offs for each algorithm was
selected such that no DDA or CDA datasets used in this
analysis had a FDR of greater than 1%.
Availability and requirements
Project name: ETISEQ
Project home page: http://www.cancerre
search.unsw.edu.au/CRCWeb.nsf/page/Elu
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Operating system: Windows, Linux
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License: Free for non-commercial use. Source code avail-
able upon request.
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